Overview

Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis

Status:
NOT_YET_RECRUITING

Trial end date:
2026-12-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical trial is to compare the combination albendazole and praziquantel versus albendazole alone in patients affected by neurocysticercosis.

Phase:

PHASE4

Details

Lead Sponsor:

R-Evolution Worldwide S.r.l. Impresa Sociale

Collaborators:

Muhimbili University of Health and Allied Sciences
National Institute for Medical Research, Tanzania
Sokoine University of Agriculture
University Ghent
University of Zambia

Treatments:

Albendazole
Praziquantel